Cardiovascular Risk Factors, Cerebrovascular Disease Burden, and Healthy Brain Aging

Clinics in Geriatric Medicine

Volumn 26, Issue 1, 2010, Pages 17-27

  Flicker, Leon ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cardiovascular risk factors; Cognitive impairment; Depression; Healthy brain aging

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HOMOCYSTEINE; METHYLENETETRAHYDROFOLIC ACID;

AGING; BRAIN FUNCTION; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILY HISTORY; HEALTH CARE POLICY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE; MEMORY; MENTAL HEALTH; MORBIDITY; MORTALITY; MULTIINFARCT DEMENTIA; OXIDATIVE STRESS; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RISK FACTOR; SITTING; SMOKING; SMOKING CESSATION;

AGING; BRAIN; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DEMENTIA; DEPRESSIVE DISORDER; HEALTH POLICY; HUMANS; RISK FACTORS;

EID: 76749156775     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2009.12.005     Document Type: Review

References (52)

1. Flicker L., Lautenschlager N.T., and Almeida O.P. Healthy mental ageing. J Br Menopause Soc 12 (2006) 92-96
2. Graham J.E., Rockwood K., Beattie B.L., et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349 (1997) 1793-1796
3. Petersen R.C., Doody R., Kurz A., et al. Current concepts in mild cognitive impairment. Arch Neurol 58 (2001) 1985-1992
4. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines (1992), World Health Organization, Geneva, Switzerland p. 42-56
5. McKeith I.G., Dickson D.W., Lowe J., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65 (2005) 1863-1872
6. Jellinger K.A. Morphologic diagnosis of "vascular dementia" - a critical update. J Neurol Sci 270 (2008) 1-12
7. Savva G.M., Wharton S.B., Ince P.G., et al. Medical research council cognitive function and ageing study. Age, neuropathology, and dementia. N Engl J Med 360 (2009) 2302-2309
8. Romero J.R., Morris J., and Pikula A. Stroke prevention: modifying risk factors. Ther Adv Cardiovasc Dis 2 (2008) 287-303
9. Skoog I., Lernfelt B., Landahl S., et al. 15-year longitudinal study of blood pressure and dementia. Lancet 347 (1996) 1141-1145
10. Kivipelto M., Helkala E.L., Laakso M.P., et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322 7300 (2001) 1447-1451
11. Luchsinger J.A., Tang M.X., Stern Y., et al. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154 (2001) 635-641
12. Almeida O.P., Hulse G.K., Lawrence D., et al. Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction 97 (2002) 15-28
13. Anstey K.J., von Sanden C., Salim A., et al. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 66 (2007) 367-378
14. Almeida O.P., Garrido G.J., Lautenschlager N.T., et al. Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzheimer disease. Am J Geriatr Psychiatry 16 (2008) 92-98
15. Mielke M.M., Rosenberg P.B., Tschanz J., et al. Vascular factors predict rate of progression in Alzheimer disease. Neurology 69 (2007) 1850-1858
16. McGuinness B., Todd S., Passmore P., et al. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 4 (2009) CD004034
17. Peters R., Beckett N., Forette F., et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial Cognitive Function Assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 7 (2008) 683-689
18. Birks J., and Flicker L. Investigational treatments for vascular cognitive impairment. Expert Opin Investig Drugs 16 (2007) 647-658
19. Almeida O.P., and Flicker L. The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning. Intern Med J 31 (2001) 290-295
20. Beer C., Ebenezer E., Fenner S., et al. Contributors to cognitive impairment in congestive heart failure: a pilot case-control study. Intern Med J 39 (2009) 600-605
21. Roberts R.O., Knopman D.S., Geda Y.E., et al. Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol Aging (2008) [Epub ahead of print]
22. Teper E., and O'Brien J.T. Vascular factors and depression. Int J Geriatr Psychiatry 23 (2008) 993-1000
23. Thombs B.D., Bass E.B., Ford D.E., et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 21 (2006) 30-38
24. Almeida O.P., Flicker L., Norman P., et al. Association of cardiovascular risk factors and disease with depression in later life. Am J Geriatr Psychiatry 15 (2007) 506-513
25. Almeida O.P., McCaul K., Hankey G.J., et al. Homocysteine and depression in later life. Arch Gen Psychiatry 65 (2008) 1286-1294
26. Chan S.S., Lyness J.M., and Conwell Y. Do cerebrovascular risk factors confer risk for suicide in later life? A case-control study. Am J Geriatr Psychiatry 15 (2007) 541-544
27. Almeida O.P. Vascular depression: myth or reality?. Int Psychogeriatr 20 (2008) 645-652
28. Bogner H.R., Morales K.H., Post E.P., et al. Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care 30 (2007) 3005-3010
29. O'Brien J.T., Erkinjuntti T., Reisberg B., et al. Vascular cognitive impairment. Lancet Neurol 2 (2003) 89-98
30. Rockwood K., Wentzel C., Hachinski V., et al. Prevalence and outcomes of vascular cognitive impairment. Neurology 54 (2000) 447-451
31. Dede D.S., Yavuz B., Yavuz B.B., et al. Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease?. J Am Geriatr Soc 55 (2007) 1613-1617
32. Khalil Z., LoGiudice D., Khodr B., et al. Impaired peripheral endothelial microvascular responsiveness in Alzheimer's disease. J Alzheimers Dis 11 (2007) 25-32
33. Almeida O.P., Garrido G.J., Beer C., et al. Coronary heart disease is associated with regional grey matter volume loss: implications for cognitive function and behaviour. Intern Med J 38 (2008) 599-606
34. Woo M.A., Macey P.M., Fonarow G.C., et al. Regional brain gray matter loss in heart failure. J Appl Phys 95 (2003) 677-684
35. Woo M.A., Macey P.M., Keens P.T., et al. Functional abnormalities in brain areas that mediate autonomic nervous system control in advanced heart failure. J Card Fail 11 (2005) 437-446
36. Xu W., Qiu C., Gatz M., et al. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 58 (2009) 71-77
37. Irie F., Fitzpatrick A.L., Lopez O.L., et al. Enhanced risk of Alzheimer disease in persons with type 2 diabetes and APOE ε4: the cardiovascular health study cognition study. Arch Neurol 65 (2008) 89-93
38. Whitmer R.A., Karter A.J., Yaffe K., et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301 (2009) 1565-1572
39. Sonnen J.A., Larson E.B., Brickell K., et al. Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol 66 (2009) 315-322
40. Wu W., Brickman A.M., Luchsinger J., et al. The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Ann Neurol 64 (2008) 698-706
41. Alexopoulos G.S., Meyers B.S., Young R.C., et al. "Vascular depression" hypothesis. Arch Gen Psychiatry 54 (1997) 915-922
42. Almeida O.P., Burton E.J., Ferrier N., et al. Depression with late onset is associated with right frontal lobe atrophy. Psychol Med 33 (2003) 675-681
43. Rainer M.K., Mucke H.A., Zehetmayer S., et al. Data from the VITA Study do not support the concept of vascular depression. Am J Geriatr Psychiatry 14 (2006) 531-537
44. Musini V.M., Tejani A.M., Bassett K., et al. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 4 (2009) CD000028
45. Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358 (2008) 1887-1898
46. Brugts J.J., Yetgin T., Hoeks S.E., et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 338 (2009) b2376
47. Manktelow B.N., and Potter J.F. Interventions in the management of serum lipids for preventing stroke recurrence. Cochrane Database Syst Rev 3 (2009) CD002091.DOI:10.1002/14651858.CD002091
48. McGuinness B., Craig D., Bullock R., et al. Statins for the prevention of dementia. Cochrane Database Syst Rev 2 (2009) CD003160
49. Hooper L., Summerbell C.D., Higgins J.P.T., et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 2 (2000) CD002137
50. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
51. Grimley E.J., and Areosa S.A. Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev 1 (2003) CD003804
52. Nelson M.R., Reid C.M., Ryan P., et al. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust 185 (2006) 487-489